Produces specialty nitrate compounds and organic peroxides inside Japanese explosives licences that chemical competitors cannot legally obtain.
At a glance
Depends onDownstream position: depends on 10 industries, supplies 5
ScaleMarket cap is above the global median
FinancialsAltman Z-Score: safe zone
Interpretations5 currently firing — 5
What this company is and how it runs — written from structure, not news.
Nature view
Nof Corporation makes specialty nitrate compounds and organic peroxides inside Japanese explosives-manufacturing facilities that require certified pressure vessels, credentialled personnel, and site layouts prescribed by the Ministry of Economy Trade and Industry — standards that pure chemical companies cannot meet without years of permitting and that blasting-agent companies cannot meet without mastering ultrapure organic chemistry. Because automotive and electronics customers in Japan and East Asia have qualified their polymerization processes to the exact initiator chemistry this specific licensed facility produces, switching to any alternative supplier triggers an 18-to-24-month requalification cycle, which means customers effectively stay put even when a cheaper option exists. Each new product grade or export market requires a fresh METI permit and, where UN precursor monitoring applies, a separate export licence, so the business cannot grow volume quickly even if the physical plant has spare capacity. The whole structure rests on a single regulatory fact: every energetic product line sits inside Japan's licensed perimeter, and if METI revises facility safety standards in a way that forces site reconstruction or suspends permits, there is no permitted facility anywhere else in the world to absorb the volume.
How does this company make money?
The company charges per unit of specialty chemical sold, with prices set by the cost of petrochemical feedstocks plus a premium for the formulation expertise and licensed production. It also earns fees for technical services — helping customers develop applications and navigate the regulatory compliance requirements that come with handling energetic materials.
What makes this company hard to replace?
Switching to a different supplier means requalifying the entire production process for energetic materials — safety testing and regulatory approval that takes 18 to 24 months. Automotive and electronics customers have built their polymerization processes around the precise initiator chemistry this facility produces, so reformulating is genuinely costly, not just inconvenient. On top of that, dual-use export licensing creates additional administrative barriers that any alternative supplier would also have to clear before they could even begin delivering.
What limits this company?
Every new product grade or export destination requires a fresh permit from Japan's Ministry of Economy Trade and Industry, and any compound that falls under UN dual-use monitoring also needs a separate export licence. Those approval timelines cap how fast the company can grow its product range or reach new markets, no matter how much spare capacity the physical plant has.
What does this company depend on?
The company cannot run without nitrocellulose feedstock from cellulose processors, petrochemical feedstocks from Japanese refineries, Japan's Ministry of Economy Trade and Industry explosives manufacturing permits, specialized pressure vessels rated for energetic material processing, and cold chain logistics providers that keep peroxides stable during transport.
Who depends on this company?
Japanese automotive manufacturers rely on the company's organic peroxide initiators to run their polymerization processes — if supply stopped, those production lines would halt. Electronics fabrication facilities across East Asia use the company's ultrapure nitrate compounds, and a disruption would contaminate semiconductor production. Construction explosive manufacturers in Southeast Asia depend on its specialty nitrate precursors to keep blasting operations running.
How does this company scale?
Once a chemical formulation and production process is developed, the knowledge behind it can in principle be reused. What cannot be reused is the regulatory work: every new jurisdiction requires its own permitting process, specialized personnel training, and facility modifications. So the chemistry scales, but the explosives handling expertise and compliance infrastructure do not.
What external forces can significantly affect this company?
When the Japanese yen weakens or strengthens, the cost competitiveness of exports to price-sensitive Asian markets shifts accordingly. International monitoring of explosives precursors under UN chemical weapons conventions is tightening, which adds administrative hurdles to exporting dual-use compounds. China's industrial policy is actively pushing domestic specialty chemical production, which could reduce Asian demand for Japanese imports over time.
Where is this company structurally vulnerable?
If Japan's Ministry of Economy Trade and Industry revises explosives-facility safety standards in a way that forces physical reconstruction of the site or suspends existing permits during re-certification, every energetic product line stops at once. There is no permitted facility in another country that could absorb the volume, so a regulatory change in Japan has no workaround.
Price is read as structure — trend, levels, range, peak and volatility drawn on the chart. It does not predict where price goes next.
What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.54%Above 5Y avg (1.75%)
Annual Rate
JPY 70.00Paid semi-annual
Payout Ratio
34.6%Sustainable
Next Ex-Dividend
Sep 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
728.33BJPY
vs all stocks (USD)
Updated Jul 15, 2026
Trailing P/E
15.61x
vs Specialty Chemicals peers
Updated Jul 15, 2026
Revenue (TTM)
257.97BJPY
vs all stocks (USD)
Updated Jul 15, 2026
Profit Margin
15.72%
vs Specialty Chemicals peers
Updated Jul 15, 2026
Beta
0.3610x
vs all stocks
Updated Jul 15, 2026
52-Week Change
-6.26%
vs all stocks
Updated Jul 15, 2026
Forward Annual Dividend Yield
2.54%
vs all stocks
Updated Jul 15, 2026
Market Capitalization
728.33BJPY
vs all stocks (USD)
Updated Jul 15, 2026
Enterprise Value
540.82BJPY
vs all stocks (USD)
Updated Jul 15, 2026
Trailing P/E
15.61x
vs Specialty Chemicals peers
Updated Jul 15, 2026
Profit Margin
15.72%
vs Specialty Chemicals peers
Updated Jul 15, 2026
Operating Margin
18.51%
vs Specialty Chemicals peers
Updated Jul 15, 2026
Return on Assets (TTM)
7.84%
vs Specialty Chemicals peers
Updated Jul 15, 2026
Shares Outstanding
226.43MSharesUpdated Jul 15, 2026
Float Shares
217.59MSharesUpdated Jul 15, 2026
% Held by Insiders
9.71%
vs all stocks
Updated Jul 15, 2026
% Held by Institutions
41.29%
vs all stocks
52-Week Low
2.51KJPYUpdated Jul 15, 2026
52-Week High
3.40KJPYUpdated Jul 15, 2026
52-Week Change
-6.26%
vs all stocks
Updated Jul 15, 2026
Beta
0.3610x
vs all stocks
Updated Jul 15, 2026
5 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Three observations have aligned: most-recent-quarter total cash is in the upper portion of its mapped range against most-recent-quarter total debt, EBITDA-to-total-liabilities is in the upper portion of its mapped range, and FCF-to-total-liabilities is in the upper portion of its mapped range.
Reads
How does this company use capital?
Multi-Year FCF With Growth And Margin
Four observations co-occur: free cash flow positive each of the last three fiscal years, revenue increased each of the last three fiscal years, trailing-statistics OCF margin elevated, and book value increased each of the last four fiscal years. The configuration describes multi-year fundamental persistence across cash flow, top line, margin, and equity accumulation.
Reads
Revenue Growing With Receivables Growing
Three observations align: revenue has increased every year over the trailing three years, receivables have increased every year over the trailing four years, and operating cash flow margin is on the industry-benchmarked scale. The picture is concurrent growth in revenue and receivables with peer-relative cash-conversion context.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Three multi-year observations co-occur: revenue increased year-over-year in each of the last three fiscal years, gross profit (absolute level) increased year-over-year in each of the last four fiscal years, and net income was positive in each of the last five fiscal years. The configuration describes growth-and-profitability persistence across three different windows.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Retained earnings are a large share of total assets; net income was positive in each of the last 5 fiscal years; shareholders' equity is in the upper part of its industry's equity-to-assets range.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score: safe zoneNotable
Altman Z-Score: 8.26
High earnings qualityNotable
Earnings Quality Score: 0.68
High structural barrier to entryNotable
Barrier to Entry: 1.26
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Market cap is above the global medianNotable
Market cap (USD): 4,445,095,110.256Global Median: 1,131,585,792.619
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthMulti-Year FCF With Growth And Margin
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthMulti-Year FCF With Growth And Margin
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthMulti-Year FCF With Growth And Margin